本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Denali Therapeutics Inc.

13.15
+0.41003.22%
盘前12.92-0.2300-1.75%07:20 EDT
成交量:121.16万
成交额:1,601.80万
市值:19.10亿
市盈率:-5.12
高:13.66
开:12.59
低:12.31
收:12.74
数据加载中...
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]